Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.
BACKGROUND: Increased levels of thyroglobulin (Tg) and thyroid-stimulating hormone (TSH) are associated with differentiated thyroid carcinoma (TC) risk, but strong epidemiological evidence is lacking. METHODS: Three hundred fifty-seven incident TC case patients (n = 300 women and 57 men; mean age at...
Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
Oxford University Press
2014
|
_version_ | 1826273941494169600 |
---|---|
author | Rinaldi, S Plummer, M Biessy, C Tsilidis, K Østergaard, J Overvad, K Tjønneland, A Halkjaer, J Boutron-Ruault, M Clavel-Chapelon, F Dossus, L Kaaks, R Lukanova, A Boeing, H Trichopoulou, A Lagiou, P Trichopoulos, D Palli, D Agnoli, C Tumino, R Vineis, P Panico, S Bueno-de-Mesquita, H Peeters, P Weiderpass, E |
author_facet | Rinaldi, S Plummer, M Biessy, C Tsilidis, K Østergaard, J Overvad, K Tjønneland, A Halkjaer, J Boutron-Ruault, M Clavel-Chapelon, F Dossus, L Kaaks, R Lukanova, A Boeing, H Trichopoulou, A Lagiou, P Trichopoulos, D Palli, D Agnoli, C Tumino, R Vineis, P Panico, S Bueno-de-Mesquita, H Peeters, P Weiderpass, E |
author_sort | Rinaldi, S |
collection | OXFORD |
description | BACKGROUND: Increased levels of thyroglobulin (Tg) and thyroid-stimulating hormone (TSH) are associated with differentiated thyroid carcinoma (TC) risk, but strong epidemiological evidence is lacking. METHODS: Three hundred fifty-seven incident TC case patients (n = 300 women and 57 men; mean age at blood collection = 51.5 years) were identified in the EPIC cohort study and matched with 2 (women) or 3 (men) control subjects using incidence density sampling. Matching included study center, sex, age, date, time, and fasting status at blood collection. Levels of total and free (f) thyroxine (T4) and triiodo-thyronine (T3), TSH, Tg, and anti-Tg antibodies (TgAb) were measured by commercially available immunoassays. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed using conditional logistic regression. All statistical tests were two-sided. RESULTS: TC risk was positively associated with Tg (OR for the highest vs lowest quartile = 9.15; 95% CI = 5.28 to 15.90; P < .001) and negatively associated with TSH level (OR = 0.56; 95% CI = 0.38 to 0.81; P = .001). Odds ratios were not modified by adjustment for weight and height and were consistent across sexes, age groups, and countries. The association with Tg was stronger in follicular than papillary TC. The odds ratio for TgAb-positivity was 1.50 (95% CI = 1.05 to 2.15; P = .03). Among case patients, TSH level was stable over time, whereas Tg level was higher in proximity to TC diagnosis. Areas under the receiver operating characteristic curve were 57% and 74% for TSH and Tg level, respectively. CONCLUSIONS: High Tg levels precede by up to 8 years the detection of TC, pointing to a long sojourn time of the disease. Low TSH levels may predispose to TC onset. Neither marker has sufficient accuracy to be a screening test. |
first_indexed | 2024-03-06T22:35:53Z |
format | Journal article |
id | oxford-uuid:59dffd47-0423-4c90-979a-a7d9d9069362 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T22:35:53Z |
publishDate | 2014 |
publisher | Oxford University Press |
record_format | dspace |
spelling | oxford-uuid:59dffd47-0423-4c90-979a-a7d9d90693622022-03-26T17:12:25ZThyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:59dffd47-0423-4c90-979a-a7d9d9069362EnglishSymplectic Elements at OxfordOxford University Press2014Rinaldi, SPlummer, MBiessy, CTsilidis, KØstergaard, JOvervad, KTjønneland, AHalkjaer, JBoutron-Ruault, MClavel-Chapelon, FDossus, LKaaks, RLukanova, ABoeing, HTrichopoulou, ALagiou, PTrichopoulos, DPalli, DAgnoli, CTumino, RVineis, PPanico, SBueno-de-Mesquita, HPeeters, PWeiderpass, EBACKGROUND: Increased levels of thyroglobulin (Tg) and thyroid-stimulating hormone (TSH) are associated with differentiated thyroid carcinoma (TC) risk, but strong epidemiological evidence is lacking. METHODS: Three hundred fifty-seven incident TC case patients (n = 300 women and 57 men; mean age at blood collection = 51.5 years) were identified in the EPIC cohort study and matched with 2 (women) or 3 (men) control subjects using incidence density sampling. Matching included study center, sex, age, date, time, and fasting status at blood collection. Levels of total and free (f) thyroxine (T4) and triiodo-thyronine (T3), TSH, Tg, and anti-Tg antibodies (TgAb) were measured by commercially available immunoassays. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed using conditional logistic regression. All statistical tests were two-sided. RESULTS: TC risk was positively associated with Tg (OR for the highest vs lowest quartile = 9.15; 95% CI = 5.28 to 15.90; P < .001) and negatively associated with TSH level (OR = 0.56; 95% CI = 0.38 to 0.81; P = .001). Odds ratios were not modified by adjustment for weight and height and were consistent across sexes, age groups, and countries. The association with Tg was stronger in follicular than papillary TC. The odds ratio for TgAb-positivity was 1.50 (95% CI = 1.05 to 2.15; P = .03). Among case patients, TSH level was stable over time, whereas Tg level was higher in proximity to TC diagnosis. Areas under the receiver operating characteristic curve were 57% and 74% for TSH and Tg level, respectively. CONCLUSIONS: High Tg levels precede by up to 8 years the detection of TC, pointing to a long sojourn time of the disease. Low TSH levels may predispose to TC onset. Neither marker has sufficient accuracy to be a screening test. |
spellingShingle | Rinaldi, S Plummer, M Biessy, C Tsilidis, K Østergaard, J Overvad, K Tjønneland, A Halkjaer, J Boutron-Ruault, M Clavel-Chapelon, F Dossus, L Kaaks, R Lukanova, A Boeing, H Trichopoulou, A Lagiou, P Trichopoulos, D Palli, D Agnoli, C Tumino, R Vineis, P Panico, S Bueno-de-Mesquita, H Peeters, P Weiderpass, E Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. |
title | Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. |
title_full | Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. |
title_fullStr | Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. |
title_full_unstemmed | Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. |
title_short | Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. |
title_sort | thyroid stimulating hormone thyroglobulin and thyroid hormones and risk of differentiated thyroid carcinoma the epic study |
work_keys_str_mv | AT rinaldis thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT plummerm thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT biessyc thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT tsilidisk thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT østergaardj thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT overvadk thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT tjønnelanda thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT halkjaerj thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT boutronruaultm thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT clavelchapelonf thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT dossusl thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT kaaksr thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT lukanovaa thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT boeingh thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT trichopouloua thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT lagioup thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT trichopoulosd thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT pallid thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT agnolic thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT tuminor thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT vineisp thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT panicos thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT buenodemesquitah thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT peetersp thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy AT weiderpasse thyroidstimulatinghormonethyroglobulinandthyroidhormonesandriskofdifferentiatedthyroidcarcinomatheepicstudy |